ovarian cancer Tagged Articles
Study finds Wyeth paid ghostwriters to promote Prempro
A federal study revealed that the pharmaceutical company Wyeth paid ghostwriters to write articles for medical journals that were favorable to the drug company’s hormone replacement therapy (HRT) Prempro, even after the drug was found to raise a woman’s risk
Cancer risk still elevated even years after stopping HRT
A study in the Journal of the American Medical Association (JAMA) reveals that women who took hormone replacement therapy (HRT) face an increased risk of cancer several years after stopping the treatment, according to an NPR report.
Wyeth to stop making HRT, focus on cancer research
Wyeth, the pharmaceutical company that makes hormone replacement therapies Prempro and Premarin, announced today that it is ending its research in its signature areas of contraceptives and menopause treatments to focus on other female problems such as ovarian and breast
New method found to detect early stage ovarian cancer
Ovarian cancer is the deadliest of all gynecologic cancers, expected to kill about 15,000 women in 2008, according to the Ovarian Cancer National Alliance. Risk factors remain a mystery; however, researchers believe a woman is at increased risk if she
Prempro user claims drug caused breast cancer
A St. Clair County woman claims her use of hormone replacement therapy drugs caused her to develop breast cancer. Minnie Louise Gray and her husband John E. Gray filed an 11-count lawsuit against Wyeth, Inc. over its drug Prempro, which
Lawsuit filed over HRT drugs blamed for breast cancer
A Jasper County woman has filed a federal lawsuit against Pfizer and Wyeth, claiming the hormone therapy drugs manufactured by the pharmaceutical companies caused her breast cancer. Scharlotte Fitzgerald says she began taking hormone replacement drugs in 1994. In 2001
Prempro user claims drug caused breast cancer
A St. Clair County woman claims her use of hormone replacement therapy drugs caused her to develop breast cancer. Minnie Louise Gray and her husband John E. Gray filed an 11-count suit against Wyeth, Inc. over its drug Prempro, which
HRT sales rep whistleblower admits improper promotion
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week. The Nevada plaintiffs are suing Wyeth, the manufacturer of Prempro and Premarin, after they each developed breast cancer attributed
